HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1501	4067 ROCKENSTEIN EM, MCCONLOGUE L, TAN H, POWER M, MASLIAH E, et al. LEVELS AND ALTERNATIVE SPLICING OF AMYLOID-BETA PROTEIN-PRECURSOR (APP) TRANSCRIPTS IN BRAINS OF APP TRANSGENIC MICE AND HUMANS WITH ALZHEIMERS-DISEASE JOURNAL OF BIOLOGICAL CHEMISTRY. 1995 NOV 24; 270 (47): 28257-28267	49	127	6	88
1502	5158 Reynolds CH, Nebreda AR, Gibb GM, Utton MA, Anderton BH Reactivating kinase/p38 phosphorylates tau protein in vitro JOURNAL OF NEUROCHEMISTRY. 1997 JUL; 69 (1): 191-198	49	94	32	69
1503	5812 [Anon], Alzheimers Assoc, Natl Inst Aging Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease" NEUROBIOLOGY OF AGING. 1998 MAR-APR; 19 (2): 109-116	49	0	3	33
1504	5901 Ince PG, Lowe J, Shaw PJ Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1998 APR; 24 (2): 104-117	49	125	17	102
1505	6032 Tait D, Riccio M, Sittler A, Scherzinger E, Santi S, et al. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix HUMAN MOLECULAR GENETICS. 1998 JUN; 7 (6): 991-997	49	79	3	31
1506	6932 Sanchez I, Xu CJ, Juo P, Kakizaka A, Blenis J, et al. Caspase-8 is required for cell death induced by expanded polyglutamine repeats NEURON. 1999 MAR; 22 (3): 623-633	49	266	9	48
1507	6956 Jicha GA, Berenfeld B, Davies P Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease JOURNAL OF NEUROSCIENCE RESEARCH. 1999 MAR 15; 55 (6): 713-723	49	59	22	36
1508	7071 Clark RSB, Kochanek PM, Chen MZ, Watkins SC, Marion DW, et al. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury FASEB JOURNAL. 1999 MAY; 13 (8): 813-821	49	103	7	51
1509	7568 Sperfeld AD, Collatz MB, Baier H, Palmbach M, Storch A, et al. FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation ANNALS OF NEUROLOGY. 1999 NOV; 46 (5): 708-715	49	67	9	25
1510	8324 Sjogren M, Rosengren L, Minthon L, Davidsson P, Blennow K, et al. Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD NEUROLOGY. 2000 MAY 23; 54 (10): 1960-1964	49	65	16	39
#	Date / Author / Journal	LCS	GCS	LCR	CR
1511	8869 Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K Role of protein phosphatase-2A and-1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain FEBS LETTERS. 2000 NOV 17; 485 (1): 87-93	49	88	19	55
1512	8917 Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, et al. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells MOLECULAR BIOLOGY OF THE CELL. 2000 DEC; 11 (12): 4093-4104	49	49	34	43
1513	9053 Hutton M Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms NEUROLOGY. 2001; 56 (11): S21-S25	49	56	25	33
1514	9081 Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR Protein oxidation in the brain in Alzheimer's disease NEUROSCIENCE. 2001; 103 (2): 373-383	49	199	10	52
1515	9392 Montine TJ, Kaye JA, Montine KS, McFarland L, Morrow JD, et al. Cerebrospinal fluid A beta(42), tau, and F-2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2001 APR; 125 (4): 510-512	49	55	6	15
1516	10184 Kung HF, Lee CW, Zhuang ZP, Kung MP, Hou C, et al. Novel stilbenes as probes for amyloid plaques JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2001 DEC 19; 123 (50): 12740-12741	49	76	9	31
1517	10467 Snowden JS, Neary D, Mann DMA Frontotemporal dementia BRITISH JOURNAL OF PSYCHIATRY. 2002 FEB; 180: 140-143	49	90	3	17
1518	10698 Ahn BH, Rhim H, Kim SY, Sung YM, Lee MY, et al. A-synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 APR 5; 277 (14): 12334-12342	49	56	21	49
1519	10846 Forman MS, Zhukareva V, Bergeron C, Chin SSM, Grossman M, et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration AMERICAN JOURNAL OF PATHOLOGY. 2002 JUN; 160 (6): 2045-2053	49	49	33	58
1520	11497 Meredith GE, Totterdell S, Petroske E, Cruz KS, Callison RC, et al. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease BRAIN RESEARCH. 2002 NOV 22; 956 (1): 156-165	49	78	22	53
#	Date / Author / Journal	LCS	GCS	LCR	CR
1521	12244 Braak H, Rub U, Gai WP, Del Tredici K Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen JOURNAL OF NEURAL TRANSMISSION. 2003 MAY; 110 (5): 517-536	49	117	37	115
1522	12806 Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, et al. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation MOLECULAR AND CELLULAR NEUROSCIENCE. 2003 OCT; 24 (2): 419-429	49	54	23	39
1523	13292 Dabir DV, Trojanowski JQ, Richter-Landsberg C, Lee VMY, Forman MS Expression of the small heat-shock protein alpha B-crystallin in tauopathies with glial pathology AMERICAN JOURNAL OF PATHOLOGY. 2004 JAN; 164 (1): 155-166	49	49	21	60
1524	13840 Mudher A, Shepherd D, Newman TA, Mildren P, Jukes JP, et al. GSK-3 beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila MOLECULAR PSYCHIATRY. 2004 MAY; 9 (5): 522-530	49	77	16	33
1525	14416 Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease JOURNAL OF NEUROCHEMISTRY. 2004 OCT; 91 (2): 451-461	49	64	36	54
1526	14538 Fernagut PO, Chesselet MF Alpha-synuclein and transgenic mouse models NEUROBIOLOGY OF DISEASE. 2004 NOV; 17 (2): 123-130	49	59	48	69
1527	14713 Hoyer W, Cherny D, Subramaniam V, Jovin TM Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro BIOCHEMISTRY. 2004 DEC 28; 43 (51): 16233-16242	49	64	46	57
1528	15825 Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, et al. Prevalence and patterns of cognitive impairment in sporadic ALS NEUROLOGY. 2005 AUG 23; 65 (4): 586-590	49	106	5	47
1529	16875 Klivenyi P, Siwek D, Gardian G, Yang LH, Starkov A, et al. Mice lacking alpha-synuclein are resistant to mitochondrial toxins NEUROBIOLOGY OF DISEASE. 2006 MAR; 21 (3): 541-548	49	67	31	52
1530	18762 Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo JOURNAL OF NEUROSCIENCE. 2007 MAR 21; 27 (12): 3338-3346	49	54	45	55
#	Date / Author / Journal	LCS	GCS	LCR	CR
1531	19208 Snowden J, Neary D, Mann D Frontotemporal lobar degeneration: clinical and pathological relationships ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 31-38	49	60	28	52
1532	2364 HOF PR, DELACOURTE A, BOURAS C DISTRIBUTION OF CORTICAL NEUROFIBRILLARY TANGLES IN PROGRESSIVE SUPRANUCLEAR PALSY - A QUANTITATIVE-ANALYSIS OF 6 CASES ACTA NEUROPATHOLOGICA. 1992 JUN; 84 (1): 45-51	48	102	2	52
1533	2758 LEE JH, GOEDERT M, HILL WD, Lee VMY, Trojanowski JQ TAU-PROTEINS ARE ABNORMALLY EXPRESSED IN OLFACTORY EPITHELIUM OF ALZHEIMER PATIENTS AND DEVELOPMENTALLY-REGULATED IN HUMAN FETAL SPINAL-CORD EXPERIMENTAL NEUROLOGY. 1993 MAY; 121 (1): 93-105	48	47	28	83
1534	2847 MUKAETOVALADINSKA EB, HARRINGTON CR, ROTH M, WISCHIK CM BIOCHEMICAL AND ANATOMICAL REDISTRIBUTION OF TAU-PROTEIN IN ALZHEIMERS- DISEASE AMERICAN JOURNAL OF PATHOLOGY. 1993 AUG; 143 (2): 565-578	48	62	14	63
1535	3132 HYMAN BT, ELVHAGE TE, REITER J EXTRACELLULAR SIGNAL-REGULATED KINASES - LOCALIZATION OF PROTEIN AND MESSENGER-RNA IN THE HUMAN HIPPOCAMPAL-FORMATION IN ALZHEIMERS-DISEASE AMERICAN JOURNAL OF PATHOLOGY. 1994 MAR; 144 (3): 565-572	48	66	12	38
1536	3578 LIPPA CF, SMITH TW, SAUNDERS AM, CROOK R, PULASKISALO D, et al. APOLIPOPROTEIN-E GENOTYPE AND LEWY BODY DISEASE NEUROLOGY. 1995 JAN; 45 (1): 97-103	48	80	5	50
1537	4027 BRION JP, COUCK AM CORTICAL AND BRAIN-STEM-TYPE LEWY BODIES ARE IMMUNOREACTIVE FOR THE CYCLIN-DEPENDENT KINASE-5 AMERICAN JOURNAL OF PATHOLOGY. 1995 NOV; 147 (5): 1465-1476	48	80	25	57
1538	4454 Black MM, Slaughter T, Moshiach S, Obrocka M, Fischer I Tau is enriched on dynamic microtubules in the distal region of growing axons JOURNAL OF NEUROSCIENCE. 1996 JUN 1; 16 (11): 3601-3619	48	99	14	62
1539	4626 MawalDewan M, Schmidt ML, Balin B, Perl DP, Lee VMY, et al. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis parkinsonism-dementia complex JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1996 OCT; 55 (10): 1051-1059	48	48	28	48
1540	4699 Arnold CS, Johnson GVW, Cole RN, Dong DLY, Lee M, et al. The microtubule-associated protein tau is extensively modified with O- linked N-acetylglucosamine JOURNAL OF BIOLOGICAL CHEMISTRY. 1996 NOV 15; 271 (46): 28741-28744	48	128	12	61
#	Date / Author / Journal	LCS	GCS	LCR	CR
1541	5591 Braak H, Braak E Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria JOURNAL OF NEURAL TRANSMISSION. 1998; 105 (8-9): 801-819	48	83	11	52
1542	5866 Jellinger KA, Bancher C Senile dementia with tangles (tangle predominant form of senile dementia) BRAIN PATHOLOGY. 1998 APR; 8 (2): 367-376	48	77	19	101
1543	5941 Nelson MD, Saykin AJ, Flashman LA, Riordan HJ Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging - A meta-analytic study ARCHIVES OF GENERAL PSYCHIATRY. 1998 MAY; 55 (5): 433-440	48	367	3	84
1544	6770 Philips MF, Muir JK, Saatman KE, Raghupathi R, Lee VMY, et al. Survival and integration of transplanted postmitotic human neurons following experimental brain injury in immunocompetent rats JOURNAL OF NEUROSURGERY. 1999 JAN; 90 (1): 116-124	48	48	16	76
1545	7136 Matsumura N, Yamazaki T, Ihara Y Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17) AMERICAN JOURNAL OF PATHOLOGY. 1999 JUN; 154 (6): 1649-1656	48	49	32	48
1546	7513 Wakabayashi K, Yoshimoto M, Fukushima T, Koide R, Horikawa Y, et al. Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 OCT; 25 (5): 363-368	48	51	16	40
1547	7680 Duda JE, Shah U, Arnold SE, Lee VMY, Trojanowski JQ The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases EXPERIMENTAL NEUROLOGY. 1999 DEC; 160 (2): 515-522	48	48	28	39
1548	7731 Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, et al. Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain NEUROLOGY. 1999 DEC 10; 53 (9): 2173-2176	48	85	3	11
1549	8500 Stone JR, Singleton RH, Povlishock JT Antibodies to the C-terminus of the beta-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury BRAIN RESEARCH. 2000 JUL 21; 871 (2): 288-302	48	64	16	86
1550	9393 Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, et al. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration BRAIN PATHOLOGY. 2001 APR; 11 (2): 144-158	48	103	47	90
#	Date / Author / Journal	LCS	GCS	LCR	CR
1551	9497 Aarsland D, Ballard C, Larsen JP, McKeith I A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2001 MAY; 16 (5): 528-536	48	101	3	42
1552	10577 Mendez I, Dagher A, Hong M, Gaudet P, Weerasinghe S, et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study - Report of three cases JOURNAL OF NEUROSURGERY. 2002 MAR; 96 (3): 589-596	48	59	2	46
1553	12088 Munishkina LA, Phelan C, Uversky VN, Fink AL Conformational behavior and aggregation of alpha-synuclein in organic solvents: Modeling the effects of membranes BIOCHEMISTRY. 2003 MAR 11; 42 (9): 2720-2730	48	98	40	107
1554	12593 Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM Rationalization of the effects of mutations on peptide and protein aggregation rates NATURE. 2003 AUG 14; 424 (6950): 805-808	48	383	9	30
1555	15483 Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, et al. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005 MAY 31; 102 (22): 8024-8029	48	98	25	49
1556	15848 Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers ANNALS OF NEUROLOGY. 2005 SEP; 58 (3): 411-422	48	82	14	48
1557	17679 Goker-Alpan O, Giasson BI, Eblan MJ, Nguyen J, Hurtig HI, et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders NEUROLOGY. 2006 SEP 12; 67 (5): 908-910	48	48	4	10
1558	18597 Ahmed Z, Mackenzie IR, Hutton ML, Dickson DW Progranulin in frontotemporal lobar degeneration and neuroinflammation JOURNAL OF NEUROINFLAMMATION. 2007 FEB 11; 4: Art. No. 7	48	59	18	93
1559	18947 Leverenz JB, Yu CE, Montine TJ, Steinbart E, Bekris LM, et al. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology BRAIN. 2007 MAY; 130: 1360-1374	48	52	21	31
1560	19643 Forman MS, Trojanowski JQ, Lee VMY TDP-43: a novel neurodegenerative proteinopathy CURRENT OPINION IN NEUROBIOLOGY. 2007 OCT; 17 (5): 548-555	48	48	34	49
#	Date / Author / Journal	LCS	GCS	LCR	CR
1561	22808 Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, et al. MRI of hippocampal volume loss in early Alzheimers disease in relation to ApoE genotype and biomarkers BRAIN. 2009 APR; 132: 1067-1077	48	48	12	54
1562	76 KUNZLE H, AKERT K EFFERENT CONNECTIONS OF CORTICAL, AREA-8 (FRONTAL EYE FIELD) IN MACACA- FASCICULARIS - REINVESTIGATION USING AUTORADIOGRAPHIC TECHNIQUE JOURNAL OF COMPARATIVE NEUROLOGY. 1977; 173 (1): 147-163	47	340	2	87
1563	334 Trojanowski JQ, Lee VMY ANTI-NEUROFILAMENT MONOCLONAL-ANTIBODIES - REAGENTS FOR THE EVALUATION OF HUMAN NEOPLASMS ACTA NEUROPATHOLOGICA. 1983; 59 (2): 155-158	47	47	2	16
1564	783 LASSMANN H, HAGN C, FISCHERCOLBRIE R, WINKLER H PRESENCE OF CHROMOGRANIN-A, CHROMOGRANIN-B AND CHROMOGRANIN-C IN BOVINE ENDOCRINE AND NERVOUS TISSUES - A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY HISTOCHEMICAL JOURNAL. 1986 JUL; 18 (7): 380-386	47	108	1	33
1565	793 LEE VMY, CARDEN MJ, SCHLAEPFER WW STRUCTURAL SIMILARITIES AND DIFFERENCES BETWEEN NEUROFILAMENT PROTEINS FROM 5 DIFFERENT SPECIES AS REVEALED USING MONOCLONAL-ANTIBODIES JOURNAL OF NEUROSCIENCE. 1986 AUG; 6 (8): 2179-2186	47	57	6	41
1566	1681 HASEGAWA M, ARAI T, IHARA Y IMMUNOCHEMICAL EVIDENCE THAT FRAGMENTS OF PHOSPHORYLATED MAP5 (MAP1B) ARE BOUND TO NEUROFIBRILLARY TANGLES IN ALZHEIMERS-DISEASE NEURON. 1990 JUN; 4 (6): 909-918	47	97	5	50
1567	1798 HISANAGA S, HIROKAWA N DEPHOSPHORYLATION-INDUCED INTERACTIONS OF NEUROFILAMENTS WITH MICROTUBULES JOURNAL OF BIOLOGICAL CHEMISTRY. 1990 DEC 15; 265 (35): 21852-21858	47	74	7	61
1568	2519 DICKSON DW, KSIEZAKREDING H, LIU WK, DAVIES P, CROWE A, et al. IMMUNOCYTOCHEMISTRY OF NEUROFIBRILLARY TANGLES WITH ANTIBODIES TO SUBREGIONS OF TAU-PROTEIN - IDENTIFICATION OF HIDDEN AND CLEAVED TAU EPITOPES AND A NEW PHOSPHORYLATION SITE ACTA NEUROPATHOLOGICA. 1992 NOV; 84 (6): 596-605	47	59	14	51
1569	3496 CITRON M, VIGOPELFREY C, TEPLOW DB, MILLER C, SCHENK D, et al. EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1994 DEC 6; 91 (25): 11993-11997	47	193	2	33
1570	3768 GOEDERT M, SPILLANTINI MG, JAKES R, CROWTHER RA, VANMECHELEN E, et al. MOLECULAR DISSECTION OF THE PAIRED HELICAL FILAMENT NEUROBIOLOGY OF AGING. 1995 MAY-JUN; 16 (3): 325-334	47	57	38	72
#	Date / Author / Journal	LCS	GCS	LCR	CR
1571	4217 Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, et al. Vascular variant of prion protein cerebral amyloidosis with tau- positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1996 JAN 23; 93 (2): 744-748	47	136	11	28
1572	5548 Tapiola T, Overmyer M, Lehtovirta M, Helisalmi S, Ramberg J, et al. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease NEUROREPORT. 1997 DEC 22; 8 (18): 3961-3963	47	66	7	18
1573	5597 Braak H, Braak E Evolution of neuronal changes in the course of Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1998; (53): 127-140	47	158	6	55
1574	5964 Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1998 MAY; 57 (5): 456-464	47	163	10	68
1575	6351 Schmidt T, Landwehrmeyer GB, Schmitt I, Trottier Y, Auburger G, et al. An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients BRAIN PATHOLOGY. 1998 OCT; 8 (4): 669-679	47	78	2	50
1576	6598 Iseki E, Marui W, Kosaka K, Akiyama H, Ueda K, et al. Degenerative terminals of the perforant pathway are human alpha- synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease NEUROSCIENCE LETTERS. 1998 DEC 18; 258 (2): 81-84	47	52	7	18
1577	7054 Hartley RS, Margulis M, Fishman PS, Lee VMY, Tang CM Functional synapses are formed between human NTera2 (NT2N, hNT) neurons grown on astrocytes JOURNAL OF COMPARATIVE NEUROLOGY. 1999 APR 28; 407 (1): 1-10	47	75	6	47
1578	7689 Newell KL, Boyer P, Gomez-Tortosa E, Hobbs W, Hedley-Whyte ET, et al. alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1999 DEC; 58 (12): 1263-1268	47	51	13	35
1579	8014 Pastor P, Ezquerra M, Munoz E, Marti MJ, Blesa R, et al. Significant association between the tau gene A0/A0 genotype and Parkinson's disease ANNALS OF NEUROLOGY. 2000 FEB; 47 (2): 242-245	47	52	8	20
1580	8031 Gao QS, Memmott J, Lafyatis R, Stamm S, Screaton G, et al. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia JOURNAL OF NEUROCHEMISTRY. 2000 FEB; 74 (2): 490-500	47	54	19	88
#	Date / Author / Journal	LCS	GCS	LCR	CR
1581	8366 El-Agnaf OMA, Irvine GB Review: Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins JOURNAL OF STRUCTURAL BIOLOGY. 2000 JUN; 130 (2-3): 300-309	47	57	28	52
1582	9412 Iwata A, Miura S, Kanazawa I, Sawada M, Nukina N alpha-synuclein forms a complex with transcription factor Elk-1 JOURNAL OF NEUROCHEMISTRY. 2001 APR; 77 (1): 239-252	47	58	17	39
1583	9569 Gotz J, Tolnay M, Barmettler R, Chen F, Probst A, et al. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau EUROPEAN JOURNAL OF NEUROSCIENCE. 2001 JUN; 13 (11): 2131-2140	47	53	36	46
1584	9621 Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, et al. Intraneuronal A beta accumulation precedes plaque formation in beta- amyloid precursor protein and presenilin-1 double-transgenic mice NEUROSCIENCE LETTERS. 2001 JUN 22; 306 (1-2): 116-120	47	140	6	19
1585	9866 Pasinetti GM Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia JOURNAL OF NEUROSCIENCE RESEARCH. 2001 SEP 15; 65 (6): 471-476	47	71	1	23
1586	9941 Blum D, Torch S, Lambeng N, Nissou MF, Benabid AL, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease PROGRESS IN NEUROBIOLOGY. 2001 OCT; 65 (2): 135-172	47	371	20	510
1587	10558 Perez M, Hernandez F, Gomez-Ramos A, Smith M, Perry G, et al. Formation of aberrant phosphotau fibrillar polymers in neural cultured cells EUROPEAN JOURNAL OF BIOCHEMISTRY. 2002 MAR; 269 (5): 1484-1489	47	65	26	47
1588	10643 Hu YY, He SS, Wang XC, Duan QH, Grundke-Iqbal I, et al. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients - An ultrasensitive bienzyme- substrate-recycle enzyme-linked Immunosorbent assay AMERICAN JOURNAL OF PATHOLOGY. 2002 APR; 160 (4): 1269-1278	47	76	21	37
1589	10918 Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats GENES & DEVELOPMENT. 2002 JUN 1; 16 (11): 1345-1355	47	459	10	47
1590	11065 Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, et al. Peripheral F-2-isoprostanes and F-4-neuroprostanes are not increased in Alzheimer's disease ANNALS OF NEUROLOGY. 2002 AUG; 52 (2): 175-179	47	67	8	22
#	Date / Author / Journal	LCS	GCS	LCR	CR
1591	12143 Parkkinen L, Soininen H, Alafuzoff I Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 APR; 62 (4): 363-367	47	53	12	20
1592	12488 Berry RW, Abraha A, Lagalwar S, LaPointe N, Gamblin TC, et al. Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment BIOCHEMISTRY. 2003 JUL 15; 42 (27): 8325-8331	47	62	10	24
1593	12932 Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli R, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease NEUROBIOLOGY OF AGING. 2003 NOV; 24 (7): 915-919	47	131	6	42
1594	13090 Gamblin TC, Berry RW, Binder LI Modeling Tau polymerization in vitro: A review and synthesis BIOCHEMISTRY. 2003 DEC 30; 42 (51): 15009-15017	47	65	62	95
1595	14915 Thompson HJ, Lifshitz J, Marklund N, Grady MS, Graham DI, et al. Lateral fluid percussion brain injury: A 15-year review and evaluation JOURNAL OF NEUROTRAUMA. 2005 JAN; 22 (1): 42-75	47	105	90	375
1596	15259 Mueller JC, Fuchs J, Hofer A, Zimprich A, Lichtner P, et al. Multiple regions of alpha-synuclein are associated with Parkinson's disease ANNALS OF NEUROLOGY. 2005 APR; 57 (4): 535-541	47	80	13	32
1597	15355 Dedmon MM, Christodoulou J, Wilson MR, Dobson CM Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 APR 15; 280 (15): 14733-14740	47	64	22	56
1598	15823 Forman MS, Lee VMY, Trojanowski JQ Nosology of Parkinson's disease: Looking for the way out of a quackmire NEURON. 2005 AUG 18; 47 (4): 479-482	47	47	16	26
1599	16221 Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, et al. Neural activity controls the synaptic accumulation of alpha-synuclein JOURNAL OF NEUROSCIENCE. 2005 NOV 23; 25 (47): 10913-10921	47	60	26	57
1600	17079 Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia ARCHIVES OF NEUROLOGY. 2006 MAY; 63 (5): 674-681	47	106	11	50

Date / Author / Journal

LCS

GCS

LCR

1501

4067 ROCKENSTEIN EM, MCCONLOGUE L, TAN H, POWER M, MASLIAH E, et al.

LEVELS AND ALTERNATIVE SPLICING OF AMYLOID-BETA PROTEIN-PRECURSOR (APP) TRANSCRIPTS IN BRAINS OF APP TRANSGENIC MICE AND HUMANS WITH ALZHEIMERS-DISEASE

JOURNAL OF BIOLOGICAL CHEMISTRY. 1995 NOV 24; 270 (47): 28257-28267

127

1502

5158 Reynolds CH, Nebreda AR, Gibb GM, Utton MA, Anderton BH

Reactivating kinase/p38 phosphorylates tau protein in vitro

JOURNAL OF NEUROCHEMISTRY. 1997 JUL; 69 (1): 191-198

1503

5812 [Anon], Alzheimers Assoc, Natl Inst Aging

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease"

NEUROBIOLOGY OF AGING. 1998 MAR-APR; 19 (2): 109-116

1504

5901 Ince PG, Lowe J, Shaw PJ

Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1998 APR; 24 (2): 104-117

125

102

1505

6032 Tait D, Riccio M, Sittler A, Scherzinger E, Santi S, et al.

Ataxin-3 is transported into the nucleus and associates with the nuclear matrix

HUMAN MOLECULAR GENETICS. 1998 JUN; 7 (6): 991-997

1506

6932 Sanchez I, Xu CJ, Juo P, Kakizaka A, Blenis J, et al.

Caspase-8 is required for cell death induced by expanded polyglutamine repeats

NEURON. 1999 MAR; 22 (3): 623-633

266

1507

6956 Jicha GA, Berenfeld B, Davies P

Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease

JOURNAL OF NEUROSCIENCE RESEARCH. 1999 MAR 15; 55 (6): 713-723

1508

7071 Clark RSB, Kochanek PM, Chen MZ, Watkins SC, Marion DW, et al.

Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury

FASEB JOURNAL. 1999 MAY; 13 (8): 813-821

103

1509

7568 Sperfeld AD, Collatz MB, Baier H, Palmbach M, Storch A, et al.

FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation

ANNALS OF NEUROLOGY. 1999 NOV; 46 (5): 708-715

1510

8324 Sjogren M, Rosengren L, Minthon L, Davidsson P, Blennow K, et al.

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

NEUROLOGY. 2000 MAY 23; 54 (10): 1960-1964

Date / Author / Journal

LCS

GCS

LCR

1511

8869 Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K

Role of protein phosphatase-2A and-1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain

FEBS LETTERS. 2000 NOV 17; 485 (1): 87-93

1512

8917 Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, et al.

Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells

MOLECULAR BIOLOGY OF THE CELL. 2000 DEC; 11 (12): 4093-4104

1513

9053 Hutton M

Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms

NEUROLOGY. 2001; 56 (11): S21-S25

1514

9081 Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR

Protein oxidation in the brain in Alzheimer's disease

NEUROSCIENCE. 2001; 103 (2): 373-383

199

1515

9392 Montine TJ, Kaye JA, Montine KS, McFarland L, Morrow JD, et al.

Cerebrospinal fluid A beta(42), tau, and F-2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2001 APR; 125 (4): 510-512

1516

10184 Kung HF, Lee CW, Zhuang ZP, Kung MP, Hou C, et al.

Novel stilbenes as probes for amyloid plaques

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2001 DEC 19; 123 (50): 12740-12741

1517

10467 Snowden JS, Neary D, Mann DMA

Frontotemporal dementia

BRITISH JOURNAL OF PSYCHIATRY. 2002 FEB; 180: 140-143

1518

10698 Ahn BH, Rhim H, Kim SY, Sung YM, Lee MY, et al.

A-synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 APR 5; 277 (14): 12334-12342

1519

10846 Forman MS, Zhukareva V, Bergeron C, Chin SSM, Grossman M, et al.

Signature tau neuropathology in gray and white matter of corticobasal degeneration

AMERICAN JOURNAL OF PATHOLOGY. 2002 JUN; 160 (6): 2045-2053

1520

11497 Meredith GE, Totterdell S, Petroske E, Cruz KS, Callison RC, et al.

Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease

BRAIN RESEARCH. 2002 NOV 22; 956 (1): 156-165

Date / Author / Journal

LCS

GCS

LCR

1521

12244 Braak H, Rub U, Gai WP, Del Tredici K

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

JOURNAL OF NEURAL TRANSMISSION. 2003 MAY; 110 (5): 517-536

117

115

1522

12806 Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, et al.

Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation

MOLECULAR AND CELLULAR NEUROSCIENCE. 2003 OCT; 24 (2): 419-429

1523

13292 Dabir DV, Trojanowski JQ, Richter-Landsberg C, Lee VMY, Forman MS

Expression of the small heat-shock protein alpha B-crystallin in tauopathies with glial pathology

AMERICAN JOURNAL OF PATHOLOGY. 2004 JAN; 164 (1): 155-166

1524

13840 Mudher A, Shepherd D, Newman TA, Mildren P, Jukes JP, et al.

GSK-3 beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila

MOLECULAR PSYCHIATRY. 2004 MAY; 9 (5): 522-530

1525

14416 Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H

Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease

JOURNAL OF NEUROCHEMISTRY. 2004 OCT; 91 (2): 451-461

1526

14538 Fernagut PO, Chesselet MF

Alpha-synuclein and transgenic mouse models

NEUROBIOLOGY OF DISEASE. 2004 NOV; 17 (2): 123-130

1527

14713 Hoyer W, Cherny D, Subramaniam V, Jovin TM

Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro

BIOCHEMISTRY. 2004 DEC 28; 43 (51): 16233-16242

1528

15825 Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, et al.

Prevalence and patterns of cognitive impairment in sporadic ALS

NEUROLOGY. 2005 AUG 23; 65 (4): 586-590

106

1529

16875 Klivenyi P, Siwek D, Gardian G, Yang LH, Starkov A, et al.

Mice lacking alpha-synuclein are resistant to mitochondrial toxins

NEUROBIOLOGY OF DISEASE. 2006 MAR; 21 (3): 541-548

1530

18762 Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo

JOURNAL OF NEUROSCIENCE. 2007 MAR 21; 27 (12): 3338-3346

Date / Author / Journal

LCS

GCS

LCR

1531

19208 Snowden J, Neary D, Mann D

Frontotemporal lobar degeneration: clinical and pathological relationships

ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 31-38

1532

2364 HOF PR, DELACOURTE A, BOURAS C

DISTRIBUTION OF CORTICAL NEUROFIBRILLARY TANGLES IN PROGRESSIVE SUPRANUCLEAR PALSY - A QUANTITATIVE-ANALYSIS OF 6 CASES

ACTA NEUROPATHOLOGICA. 1992 JUN; 84 (1): 45-51

102

1533

2758 LEE JH, GOEDERT M, HILL WD, Lee VMY, Trojanowski JQ

TAU-PROTEINS ARE ABNORMALLY EXPRESSED IN OLFACTORY EPITHELIUM OF ALZHEIMER PATIENTS AND DEVELOPMENTALLY-REGULATED IN HUMAN FETAL SPINAL-CORD

EXPERIMENTAL NEUROLOGY. 1993 MAY; 121 (1): 93-105

1534

2847 MUKAETOVALADINSKA EB, HARRINGTON CR, ROTH M, WISCHIK CM

BIOCHEMICAL AND ANATOMICAL REDISTRIBUTION OF TAU-PROTEIN IN ALZHEIMERS- DISEASE

AMERICAN JOURNAL OF PATHOLOGY. 1993 AUG; 143 (2): 565-578

1535

3132 HYMAN BT, ELVHAGE TE, REITER J

EXTRACELLULAR SIGNAL-REGULATED KINASES - LOCALIZATION OF PROTEIN AND MESSENGER-RNA IN THE HUMAN HIPPOCAMPAL-FORMATION IN ALZHEIMERS-DISEASE

AMERICAN JOURNAL OF PATHOLOGY. 1994 MAR; 144 (3): 565-572

1536

3578 LIPPA CF, SMITH TW, SAUNDERS AM, CROOK R, PULASKISALO D, et al.

APOLIPOPROTEIN-E GENOTYPE AND LEWY BODY DISEASE

NEUROLOGY. 1995 JAN; 45 (1): 97-103

1537

4027 BRION JP, COUCK AM

CORTICAL AND BRAIN-STEM-TYPE LEWY BODIES ARE IMMUNOREACTIVE FOR THE CYCLIN-DEPENDENT KINASE-5

AMERICAN JOURNAL OF PATHOLOGY. 1995 NOV; 147 (5): 1465-1476

1538

4454 Black MM, Slaughter T, Moshiach S, Obrocka M, Fischer I

Tau is enriched on dynamic microtubules in the distal region of growing axons

JOURNAL OF NEUROSCIENCE. 1996 JUN 1; 16 (11): 3601-3619

1539

4626 MawalDewan M, Schmidt ML, Balin B, Perl DP, Lee VMY, et al.

Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis parkinsonism-dementia complex

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1996 OCT; 55 (10): 1051-1059

1540

4699 Arnold CS, Johnson GVW, Cole RN, Dong DLY, Lee M, et al.

The microtubule-associated protein tau is extensively modified with O- linked N-acetylglucosamine

JOURNAL OF BIOLOGICAL CHEMISTRY. 1996 NOV 15; 271 (46): 28741-28744

128

Date / Author / Journal

LCS

GCS

LCR

1541

5591 Braak H, Braak E

Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria

JOURNAL OF NEURAL TRANSMISSION. 1998; 105 (8-9): 801-819

1542

5866 Jellinger KA, Bancher C

Senile dementia with tangles (tangle predominant form of senile dementia)

BRAIN PATHOLOGY. 1998 APR; 8 (2): 367-376

101

1543

5941 Nelson MD, Saykin AJ, Flashman LA, Riordan HJ

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging - A meta-analytic study

ARCHIVES OF GENERAL PSYCHIATRY. 1998 MAY; 55 (5): 433-440

367

1544

6770 Philips MF, Muir JK, Saatman KE, Raghupathi R, Lee VMY, et al.

Survival and integration of transplanted postmitotic human neurons following experimental brain injury in immunocompetent rats

JOURNAL OF NEUROSURGERY. 1999 JAN; 90 (1): 116-124

1545

7136 Matsumura N, Yamazaki T, Ihara Y

Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)

AMERICAN JOURNAL OF PATHOLOGY. 1999 JUN; 154 (6): 1649-1656

1546

7513 Wakabayashi K, Yoshimoto M, Fukushima T, Koide R, Horikawa Y, et al.

Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1999 OCT; 25 (5): 363-368

1547

7680 Duda JE, Shah U, Arnold SE, Lee VMY, Trojanowski JQ

The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases

EXPERIMENTAL NEUROLOGY. 1999 DEC; 160 (2): 515-522

1548

7731 Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, et al.

Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain

NEUROLOGY. 1999 DEC 10; 53 (9): 2173-2176

1549

8500 Stone JR, Singleton RH, Povlishock JT

Antibodies to the C-terminus of the beta-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury

BRAIN RESEARCH. 2000 JUL 21; 871 (2): 288-302

1550

9393 Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, et al.

Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration

BRAIN PATHOLOGY. 2001 APR; 11 (2): 144-158

103

Date / Author / Journal

LCS

GCS

LCR

1551

9497 Aarsland D, Ballard C, Larsen JP, McKeith I

A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2001 MAY; 16 (5): 528-536

101

1552

10577 Mendez I, Dagher A, Hong M, Gaudet P, Weerasinghe S, et al.

Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study - Report of three cases

JOURNAL OF NEUROSURGERY. 2002 MAR; 96 (3): 589-596

1553

12088 Munishkina LA, Phelan C, Uversky VN, Fink AL

Conformational behavior and aggregation of alpha-synuclein in organic solvents: Modeling the effects of membranes

BIOCHEMISTRY. 2003 MAR 11; 42 (9): 2720-2730

107

1554

12593 Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM

Rationalization of the effects of mutations on peptide and protein aggregation rates

NATURE. 2003 AUG 14; 424 (6950): 805-808

383

1555

15483 Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, et al.

Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005 MAY 31; 102 (22): 8024-8029

1556

15848 Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, et al.

Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers

ANNALS OF NEUROLOGY. 2005 SEP; 58 (3): 411-422

1557

17679 Goker-Alpan O, Giasson BI, Eblan MJ, Nguyen J, Hurtig HI, et al.

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders

NEUROLOGY. 2006 SEP 12; 67 (5): 908-910

1558

18597 Ahmed Z, Mackenzie IR, Hutton ML, Dickson DW

Progranulin in frontotemporal lobar degeneration and neuroinflammation

JOURNAL OF NEUROINFLAMMATION. 2007 FEB 11; 4: Art. No. 7

1559

18947 Leverenz JB, Yu CE, Montine TJ, Steinbart E, Bekris LM, et al.

A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology

BRAIN. 2007 MAY; 130: 1360-1374

1560

19643 Forman MS, Trojanowski JQ, Lee VMY

TDP-43: a novel neurodegenerative proteinopathy

CURRENT OPINION IN NEUROBIOLOGY. 2007 OCT; 17 (5): 548-555

Date / Author / Journal

LCS

GCS

LCR

1561

22808 Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, et al.

MRI of hippocampal volume loss in early Alzheimers disease in relation to ApoE genotype and biomarkers

BRAIN. 2009 APR; 132: 1067-1077

1562

76 KUNZLE H, AKERT K

EFFERENT CONNECTIONS OF CORTICAL, AREA-8 (FRONTAL EYE FIELD) IN MACACA- FASCICULARIS - REINVESTIGATION USING AUTORADIOGRAPHIC TECHNIQUE

JOURNAL OF COMPARATIVE NEUROLOGY. 1977; 173 (1): 147-163

340

1563

334 Trojanowski JQ, Lee VMY

ANTI-NEUROFILAMENT MONOCLONAL-ANTIBODIES - REAGENTS FOR THE EVALUATION OF HUMAN NEOPLASMS

ACTA NEUROPATHOLOGICA. 1983; 59 (2): 155-158

1564

783 LASSMANN H, HAGN C, FISCHERCOLBRIE R, WINKLER H

PRESENCE OF CHROMOGRANIN-A, CHROMOGRANIN-B AND CHROMOGRANIN-C IN BOVINE ENDOCRINE AND NERVOUS TISSUES - A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY

HISTOCHEMICAL JOURNAL. 1986 JUL; 18 (7): 380-386

108

1565

793 LEE VMY, CARDEN MJ, SCHLAEPFER WW

JOURNAL OF NEUROSCIENCE. 1986 AUG; 6 (8): 2179-2186

1566

1681 HASEGAWA M, ARAI T, IHARA Y

IMMUNOCHEMICAL EVIDENCE THAT FRAGMENTS OF PHOSPHORYLATED MAP5 (MAP1B) ARE BOUND TO NEUROFIBRILLARY TANGLES IN ALZHEIMERS-DISEASE

NEURON. 1990 JUN; 4 (6): 909-918

1567

1798 HISANAGA S, HIROKAWA N

DEPHOSPHORYLATION-INDUCED INTERACTIONS OF NEUROFILAMENTS WITH MICROTUBULES

JOURNAL OF BIOLOGICAL CHEMISTRY. 1990 DEC 15; 265 (35): 21852-21858

1568

2519 DICKSON DW, KSIEZAKREDING H, LIU WK, DAVIES P, CROWE A, et al.

IMMUNOCYTOCHEMISTRY OF NEUROFIBRILLARY TANGLES WITH ANTIBODIES TO SUBREGIONS OF TAU-PROTEIN - IDENTIFICATION OF HIDDEN AND CLEAVED TAU EPITOPES AND A NEW PHOSPHORYLATION SITE

ACTA NEUROPATHOLOGICA. 1992 NOV; 84 (6): 596-605

1569

3496 CITRON M, VIGOPELFREY C, TEPLOW DB, MILLER C, SCHENK D, et al.

EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1994 DEC 6; 91 (25): 11993-11997

193

1570

3768 GOEDERT M, SPILLANTINI MG, JAKES R, CROWTHER RA, VANMECHELEN E, et al.

MOLECULAR DISSECTION OF THE PAIRED HELICAL FILAMENT

NEUROBIOLOGY OF AGING. 1995 MAY-JUN; 16 (3): 325-334

Date / Author / Journal

LCS

GCS

LCR

1571

4217 Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, et al.

Vascular variant of prion protein cerebral amyloidosis with tau- positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1996 JAN 23; 93 (2): 744-748

136

1572

5548 Tapiola T, Overmyer M, Lehtovirta M, Helisalmi S, Ramberg J, et al.

The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease

NEUROREPORT. 1997 DEC 22; 8 (18): 3961-3963

1573

5597 Braak H, Braak E

Evolution of neuronal changes in the course of Alzheimer's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 1998; (53): 127-140

158

1574

5964 Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H

Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1998 MAY; 57 (5): 456-464

163

1575

6351 Schmidt T, Landwehrmeyer GB, Schmitt I, Trottier Y, Auburger G, et al.

An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients

BRAIN PATHOLOGY. 1998 OCT; 8 (4): 669-679

1576

6598 Iseki E, Marui W, Kosaka K, Akiyama H, Ueda K, et al.

Degenerative terminals of the perforant pathway are human alpha- synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease

NEUROSCIENCE LETTERS. 1998 DEC 18; 258 (2): 81-84

1577

7054 Hartley RS, Margulis M, Fishman PS, Lee VMY, Tang CM

Functional synapses are formed between human NTera2 (NT2N, hNT) neurons grown on astrocytes

JOURNAL OF COMPARATIVE NEUROLOGY. 1999 APR 28; 407 (1): 1-10

1578

7689 Newell KL, Boyer P, Gomez-Tortosa E, Hobbs W, Hedley-Whyte ET, et al.

alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1999 DEC; 58 (12): 1263-1268

1579

8014 Pastor P, Ezquerra M, Munoz E, Marti MJ, Blesa R, et al.

Significant association between the tau gene A0/A0 genotype and Parkinson's disease

ANNALS OF NEUROLOGY. 2000 FEB; 47 (2): 242-245

1580

8031 Gao QS, Memmott J, Lafyatis R, Stamm S, Screaton G, et al.

Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia

JOURNAL OF NEUROCHEMISTRY. 2000 FEB; 74 (2): 490-500

Date / Author / Journal

LCS

GCS

LCR

1581

8366 El-Agnaf OMA, Irvine GB

Review: Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins

JOURNAL OF STRUCTURAL BIOLOGY. 2000 JUN; 130 (2-3): 300-309

1582

9412 Iwata A, Miura S, Kanazawa I, Sawada M, Nukina N

alpha-synuclein forms a complex with transcription factor Elk-1

JOURNAL OF NEUROCHEMISTRY. 2001 APR; 77 (1): 239-252

1583

9569 Gotz J, Tolnay M, Barmettler R, Chen F, Probst A, et al.

Oligodendroglial tau filament formation in transgenic mice expressing G272V tau

EUROPEAN JOURNAL OF NEUROSCIENCE. 2001 JUN; 13 (11): 2131-2140

1584

9621 Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, et al.

Intraneuronal A beta accumulation precedes plaque formation in beta- amyloid precursor protein and presenilin-1 double-transgenic mice

NEUROSCIENCE LETTERS. 2001 JUN 22; 306 (1-2): 116-120

140

1585

9866 Pasinetti GM

Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia

JOURNAL OF NEUROSCIENCE RESEARCH. 2001 SEP 15; 65 (6): 471-476

1586

9941 Blum D, Torch S, Lambeng N, Nissou MF, Benabid AL, et al.

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

PROGRESS IN NEUROBIOLOGY. 2001 OCT; 65 (2): 135-172

371

510

1587

10558 Perez M, Hernandez F, Gomez-Ramos A, Smith M, Perry G, et al.

Formation of aberrant phosphotau fibrillar polymers in neural cultured cells

EUROPEAN JOURNAL OF BIOCHEMISTRY. 2002 MAR; 269 (5): 1484-1489

1588

10643 Hu YY, He SS, Wang XC, Duan QH, Grundke-Iqbal I, et al.

Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients - An ultrasensitive bienzyme- substrate-recycle enzyme-linked Immunosorbent assay

AMERICAN JOURNAL OF PATHOLOGY. 2002 APR; 160 (4): 1269-1278

1589

10918 Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, et al.

ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats

GENES & DEVELOPMENT. 2002 JUN 1; 16 (11): 1345-1355

459

1590

11065 Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, et al.

Peripheral F-2-isoprostanes and F-4-neuroprostanes are not increased in Alzheimer's disease

ANNALS OF NEUROLOGY. 2002 AUG; 52 (2): 175-179

Date / Author / Journal

LCS

GCS

LCR

1591

12143 Parkkinen L, Soininen H, Alafuzoff I

Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 APR; 62 (4): 363-367

1592

12488 Berry RW, Abraha A, Lagalwar S, LaPointe N, Gamblin TC, et al.

Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment

BIOCHEMISTRY. 2003 JUL 15; 42 (27): 8325-8331

1593

12932 Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli R, et al.

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease

NEUROBIOLOGY OF AGING. 2003 NOV; 24 (7): 915-919

131

1594

13090 Gamblin TC, Berry RW, Binder LI

Modeling Tau polymerization in vitro: A review and synthesis

BIOCHEMISTRY. 2003 DEC 30; 42 (51): 15009-15017

1595

14915 Thompson HJ, Lifshitz J, Marklund N, Grady MS, Graham DI, et al.

Lateral fluid percussion brain injury: A 15-year review and evaluation

JOURNAL OF NEUROTRAUMA. 2005 JAN; 22 (1): 42-75

105

375

1596

15259 Mueller JC, Fuchs J, Hofer A, Zimprich A, Lichtner P, et al.

Multiple regions of alpha-synuclein are associated with Parkinson's disease

ANNALS OF NEUROLOGY. 2005 APR; 57 (4): 535-541

1597

15355 Dedmon MM, Christodoulou J, Wilson MR, Dobson CM

Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 APR 15; 280 (15): 14733-14740

1598

15823 Forman MS, Lee VMY, Trojanowski JQ

Nosology of Parkinson's disease: Looking for the way out of a quackmire

NEURON. 2005 AUG 18; 47 (4): 479-482

1599

16221 Fortin DL, Nemani VM, Voglmaier SM, Anthony MD, Ryan TA, et al.

Neural activity controls the synaptic accumulation of alpha-synuclein

JOURNAL OF NEUROSCIENCE. 2005 NOV 23; 25 (47): 10913-10921

1600

17079 Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, et al.

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia

ARCHIVES OF NEUROLOGY. 2006 MAY; 63 (5): 674-681

106

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records